These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term disease control in multiple myeloma: the impact of the dual mechanism of action of lenalidomide. Introduction and overview. San-Miguel JF Blood Rev; 2010 Nov; 24 Suppl 1():S1-3. PubMed ID: 21126631 [No Abstract] [Full Text] [Related]
3. Lenalidomide in multiple myeloma: current role and future directions. Zeldis JB; Knight RD; Jacques C; Tozer A; Bizzari JP Expert Opin Pharmacother; 2010 Apr; 11(5):829-42. PubMed ID: 20210686 [TBL] [Abstract][Full Text] [Related]
4. Future directions in immunomodulatory therapy. Lonial S Med Oncol; 2010 Jun; 27 Suppl 1():S62-6. PubMed ID: 20012563 [TBL] [Abstract][Full Text] [Related]
5. Lenalidomide and thalidomide: an evolving paradigm for the management of multiple myeloma. Anderson KC; Prince HM Semin Hematol; 2005 Oct; 42(4 Suppl 4):S1-2. PubMed ID: 16344096 [No Abstract] [Full Text] [Related]
6. Lenalidomide in the treatment of multiple myeloma: a review. Armoiry X; Aulagner G; Facon T J Clin Pharm Ther; 2008 Jun; 33(3):219-26. PubMed ID: 18452408 [TBL] [Abstract][Full Text] [Related]
11. [Therapy of multiple myeloma and monitoring of the response]. Rapazzini P; Bettini R; Masini M; Steidl L; Ferrari V; Piantanida S Recenti Prog Med; 1986 Feb; 77(2):95-9. PubMed ID: 3715177 [No Abstract] [Full Text] [Related]
12. [Multiple myeloma: therapeutic response to 2 modalities of chemotherapy]. Lira P; Walker B; Grebe G Rev Med Chil; 1986 May; 114(5):436-40. PubMed ID: 3589221 [No Abstract] [Full Text] [Related]
13. [On the road to cure of multiple myeloma?]. Löwenberg B; Sonneveld P Ned Tijdschr Geneeskd; 1992 Apr; 136(14):669-71. PubMed ID: 1560851 [No Abstract] [Full Text] [Related]
14. [Current and future approaches to therapy for multiple myeloma]. Nara N Gan To Kagaku Ryoho; 1995 Jan; 22(1):9-15. PubMed ID: 7826084 [TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of multiple myeloma]. Estape J; Antón I; Daniels M; Bladé J; Domingo A; Rubio D Sangre (Barc); 1984; 29(5):936-9. PubMed ID: 6523344 [No Abstract] [Full Text] [Related]
16. [Current aspects of treatment of multiple myeloma]. Tribalto M; Avvisati G; Cantonetti M; Catalano G; Giovangrossi P; Masi M; Petrucci MT; Venditti A; Papa G Ann Ital Med Int; 1988; 3(3):193-202. PubMed ID: 3152856 [No Abstract] [Full Text] [Related]
17. [Multiple myeloma]. Ludwig CU; Hofmann V Schweiz Rundsch Med Prax; 1986 Apr; 75(15):421-6. PubMed ID: 3083497 [No Abstract] [Full Text] [Related]
18. Duration of survival in patients with myeloma treated with thalidomide. Barlogie B; Shaughnessy JD; Crowley J N Engl J Med; 2008 Jul; 359(2):210-2. PubMed ID: 18614793 [No Abstract] [Full Text] [Related]
19. Multiple myeloma in the era of novel agents. Dimopoulos MA; Attal M Semin Hematol; 2009 Apr; 46(2):107-9. PubMed ID: 19389493 [No Abstract] [Full Text] [Related]
20. [Treatment of multiple myeloma: renal function in relation to its prognosis]. Akashi M; Ohta M; Kitagawa S; Furukawa Y; Takeda K; Muroi K; Komatsu N; Ikeda K; Ohsaka A; Yoshida M Rinsho Ketsueki; 1988 Nov; 29(11):1991-7. PubMed ID: 3236408 [No Abstract] [Full Text] [Related] [Next] [New Search]